![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Monthly dosing of ARC-520 in chronically hepatitis B virus infected chimpanzees produces rapid, deep and durable reductions in circulating viral antigens
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Christine Ilse Wooddell1 , Deborah Chavez2 , Jason E. Goetzmann3 , Lena Marja Notvall-Elkey2 , Helen Lee2 , Bernadette Guerra2 , Ryan M Peterson1 , Courtney Nicole Johnson , Julia O Hegge , Robert Gish4 , Stephen Locarnini3 , Christopher R Anzalone1 , Robert E. Lanford2 , David L Lewis 1
1Arrowhead Research Corporation, Madison, WI;
2 Texas Biomedical Research Institute, San Antonio, TX;
3 University of Louisiana, Lafayette, LA;
4 Stanford University Medical Center, San Diego, CA;
5 Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
![AASLD1.gif](../images/120215/120215-5/AASLD1.gif)
![AASLD2.gif](../images/120215/120215-5/AASLD2.gif)
![AASLD3.gif](../images/120215/120215-5/AASLD3.gif)
![AASLD4.gif](../images/120215/120215-5/AASLD4.gif)
![AASLD5.gif](../images/120215/120215-5/AASLD5.gif)
![AASLD6.gif](../images/120215/120215-5/AASLD6.gif)
![AASLD7.gif](../images/120215/120215-5/AASLD7.gif)
![AASLD8.gif](../images/120215/120215-5/AASLD8.gif)
![AASLD9.gif](../images/120215/120215-5/AASLD9.gif)
![AASLD10.gif](../images/120215/120215-5/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|